Craig Martin is the course coordinator for the comprehensive infectious diseases course in the Doctor of Pharmacy curriculum. He is busting myths and sharing truth about COVID-19 and its impact your community.
UK received $3 million from the National Institute on Drug Abuse and National Institute on General Medical Sciences to fund new opioid-related research in the criminal justice system.
UK officials provided updates on the Kentucky Viral Hepatitis Treatment Project (KeY Treat), a three-year, $15 million study co-funded by NCI and NIDA with the ultimate goal of eradicating the hepatitis C virus (HCV) in Perry County, KY.
Jennifer Havens has spent the past decade studying the transmission of infectious disease and advocating for the expansion of harm reduction programs. That work entails understanding the link between two health burdens facing the nation, the opioid crisis and cancer.
Two collaborating laboratories at the University of Kentucky were able to establish the events within white blood cells that progresses from inflammasome activation to a type of programmed cell death called pyroptosis -- and culminates in the damaging blood clots.
A collaborative program aimed at preventing new HIV infections in Kentucky, as well as expanding education and care for persons living with HIV, is being launched in Northern Kentucky and throughout the Commonwealth.
While it isn’t typically the role of emergency medicine clinicians to identify chronic diseases, Dr. J. Daniel Moore, assistant professor of emergency medicine in the University of Kentucky College of Medicine, knew it had to become their job.
A team led by Changcheng Zhou in the UK Department of Pharmacology and Nutritional Sciences has discovered a likely pathway by which antiretroviral drugs effect liver disease.
Olivia Prosper, an assistant professor of mathematics in the UK College of Arts and Sciences, is lead principal investigator on a project that may help reduce the threat of drug-resistant pathogens to global health.
